Metastatic prostate carcinoma

Metastatic prostate carcinoma is an advanced stage of malignancy originating in the epithelial tissue of the prostate gland that has disseminated beyond the pelvis to distant anatomical sites

Metastatic prostate carcinoma is an advanced stage of malignancy originating in the epithelial tissue of the prostate gland that has disseminated beyond the pelvis to distant anatomical sites Affecting primarily adult and elderly males, it most characteristically metastasizes via hematogenous and lymphatic routes to the axial and appendicular skeleton—often producing osteoblastic lesions—as well as non-regional lymph nodes and, less frequently, visceral organs such as the liver and lungs

Metastatic prostate carcinoma is an advanced stage of malignancy originating in the epithelial tissue of the prostate gland that has disseminated beyond the pelvis to distant anatomical sites

Affecting primarily adult and elderly males, it most characteristically metastasizes via hematogenous and lymphatic routes to the axial and appendicular skeleton—often producing osteoblastic lesions—as well as non-regional lymph nodes and, less frequently, visceral organs such as the liver and lungs

Affecting primarily adult and elderly males, it most characteristically metastasizes via hematogenous and lymphatic routes to the axial and appendicular skeleton—often producing osteoblastic lesions—as well as non-regional lymph nodes and, less frequently, visceral organs such as the liver and lungs

Pathophysiologically, the tumor cells escape local glandular architecture, enter the circulation, and seed target microenvironments, presenting clinically with elevated serum prostate-specific antigen, localized bone pain, skeletal-related events, or systemic cachexia

Pathophysiologically, the tumor cells escape local glandular architecture, enter the circulation, and seed target microenvironments, presenting clinically with elevated serum prostate-specific antigen, localized bone pain, skeletal-related events, or systemic cachexia

Pathophysiologically, the tumor cells escape local glandular architecture, enter the circulation, and seed target microenvironments, presenting clinically with elevated serum prostate-specific antigen, localized bone pain, skeletal-related events, or systemic cachexia